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Abstract: The phenolic composition of hydroethanolic extracts of Mentha aquatica L., Lavandula dentata
L. and Leonurus cardiaca L., obtained from plants grown under organic cultivation, was determined
and their hepatoprotective effects were investigated in vitro. L. cardiaca extract was rich in
phenylethenoid glycosides, especially lavandolifolioside (254 ± 36 µg/mg), whereas rosmarinic
acid and eriodictyol-O-rutinoside were the major phenolic compounds of L. dentata and M. aquatica
extracts, accounting for 68 ± 7 µg/mg and 145 ± 22 µg/mg, respectively. These differential phenolic
components presumably account for their dissimilar antioxidant properties. While L. cardiaca extract
showed moderate biological effects, M. aquatica extract displayed high antioxidant activity in chemical
models, and that of L. dentata was effective in counteracting potassium dichromate-induced ROS
generation in human hepatocarcinoma cells. Moreover, M. aquatica extract (50 µg/mL) and its mixture
(50%/50%) with L. dentata extract displayed an effective cytoprotective effect.
Keywords: Mentha; Lavandula; Leonurus; liver diseases; HepG2 cells; antioxidant; phenolic compounds;
UHPLC-DAD-ESI-MSn
1. Introduction
Liver diseases comprise a large number of conditions, either caused by genetic modifications or,
more frequently, by viruses, alcohol abuse, toxins or drugs. Liver injury induced by toxins and drugs,
haemochromatosis, hepatitis, cirrhosis, and hepatocellular carcinoma are among liver conditions with
poor response to available treatments [1].
In recent decades, phytochemicals from plants have been proposed as health supplements
acting as preventive agents or for treatment in patients with liver disorders [2]. In this context,
polyphenols represent one of the groups with most interest [3] due to their claimed antioxidant and
anti-inflammatory properties [4,5]. In fact, oxidative and inflammatory processes are recognized as
critical in the pathogenesis and progression of liver conditions [5].
Lamiaceae family is one of the most applied in traditional medicine, as it encloses many plant
species which are claimed to exert important pharmacological activities, including antioxidant,
antiproliferative, anti-tumoral, anti-inflammatory, antimicrobial, analgesic, and neuroprotective,
among others [4]. Mentha aquatica L., Lavandula dentata L. and Leonurus cardiaca L. are three of such
species, being used for centuries in traditional medicine for several purposes. In particular, the first is
frequently applied in the treatment of external inflammation and in inflammation-related diseases, such
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as rheumatism, although it is also used as a vermifuge, in the treatment against colds and respiratory
problems; to counteract mental illnesses or disorders of the central nervous system; and to attenuate
menstruation problems, as a stimulant and as an emetic and astringent agent [6–8]. In turn, French
lavender, or Lavandula dentata, has been used as an antidiabetic agent [9] and in cold and renal colic
treatments [10], while Leonurus cardiaca (motherwort) usages include sedative, uterotonic, diuretic,
cardiotonic, and hypotensive, as well as bronchial asthma protection [11].
At the scientific level, the bioactive properties of M. aquatica, L. dentata and L. cardiaca have been
mostly associated with their phenolic constituents, which are generally major components in extracts
obtained with polar solvents (e.g., water, ethanol, methanol, water/alcohol or water/acetone mixtures).
The antioxidant capacity of polar extracts from these three plants has been previously tested through
chemical antiradical assays [12–20]. Besides, neuroprotective effects of methanolic and aqueous extracts
of M. aquatica aerial parts were shown to counteract oxidative stress in an H2O2-induced toxicity model
in PC12 cells, along with the high ability to inhibit monoamine oxidase (MAO) and a moderate affinity
towards GABAA receptor [6,21]. Besides, hydroethanolic extracts of this plant were reported to exhibit
promising antiproliferative and anti-inflammatory activities, as demonstrated in MCF-7 human breast
cancer cells [22] and in an in-vivo mice model [7], respectively.
In contrast to M. aquatica, L. dentata extracts have been scarcely studied. Still, promising
antiproliferative and apoptotic activities were demonstrated in MCF-7 cells [18]. Moreover,
the anti-inflammatory effects of hydromethanolic extracts from this plant were evidenced using
bone marrow-derived macrophages and murine epithelial cell lines, as well as in mice [18]. Notably,
the anti-inflammatory activity of L. cardiaca was also suggested by Flemmig et al., when demonstrating
the high lactoperoxidase activity of 70% ethanol extracts [23]. Besides, high in-vitro immunomodulatory
potential was reported for an hydroacetonic extract in HUVECs cells due to their effects on viability,
apoptosis, NO• production, cytotoxicity, and platelet-activating factor secretion. This extract has also
shown to be capable of reducing platelet aggregation [20].
Taking into account the claimed antioxidant and anti-inflammatory potential of M. aquatica,
L. dentata and L. cardiaca polar extracts, we decided to evaluate the hepatoprotective activities of
hydroethanolic extracts obtained from these three plants and investigate the relationship between their
antioxidant properties and their specific phenolic composition. Interestingly, in contrast to previous
studies on these extracts that were mostly obtained from wild plants, the botanical samples herein
used have been cultivated under an organic regime, which is currently pointed as one important
market strategy [24]. In fact, organic cultivation is recognized as a sustainable agricultural system,
and medicinal and aromatic products produced under this system are readily accepted in global
markets and command higher prices than those grown with chemical inputs [7], also claiming to
contain higher amounts of specific phytochemicals, namely phenolic compounds [25,26].
2. Materials and Methods
2.1. Chemicals
BHA (butylated hydroxyanisole) and DPPH• (2,2-diphenyl-2-picrylhydrazyl radical) were
obtained from Sigma Chemical Co (St Louis, MO, USA). Porcine trypsin was purchased from Roche
(Barcelona, Spain). Tripan blue, dimetilsulfoxide (DMSO), “Minimum Essential Medium Eagle (MEM)”
and RPMI-1640 culture media, mix of antibiotics and antimycotic, sodium piruvate, sodium bicarbonate,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), dichlorofluorescein diacetate,
cisplatin, and potassium dichromate were purchased from Sigma-Aldrich (Madrid, Spain) and
fetal bovine serum (FBS) was obtained from T.D.I. (Madrid, Spain). The phenolic standards
eriodictyol-7-O-glucoside, naringenin-7-O-glucoside, luteolin-7-O-glucoside, quercetin-7-O-rutinoside,
rosmarinic acid, and verbascoside were obtained from Extrasynthese (Genay Cedex, France). Ascorbic
acid, formic acid and ethanol were purchased from Panreac (Barcelona). n-Hexane, methanol and
acetonitrile, all with HPLC purity, were purchased from Lab-Scan (Lisbon, Portugal).
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2.2. Plant Material and Obtention of Phenolic-Rich Extracts
Aerial parts (leaves and stems) of M. aquatica and L. cardiaca and flowers of L. dentata were purchased
from Ervital (Mezio-Castro Daire, Portugal, GPS coordinates 40.976351, −7.903492), a pioneer company
in Portugal in organic farming, specialized in the production and commercialization of aromatic and
medicinal plants using an organic regime growth in fields of Serra do Montemuro, located in Montemuro
region at about 1000 m of altitude. The plants have been cultivated under the general conditions
described by Afonso et al. [27]. After collection, the aerial parts were dried in a ventilated incubator at
20 to 35 ◦C for 3 to 5 days.
The extracts were prepared after defatting the plant powder with n-hexane, (1:30), following the
general procedure described by Pereira et al. [28] i.e., the defatted residue was extracted six times with
150 mL of 80% ethanolic solution (v/v) at room temperature for 1 h.
The resulting dispersions were combined, filtrated through a G3 sintered plate filter, concentrated,
and then treated in order to obtain phenolic-rich extracts [28]. In detail, approximately 0.4 g of each
ethanolic extract was dissolved in 15 mL of water and eluted in three Strata SPE C18-E cartridges (2 g,
Waters, Milford, MA, USA). The cartridges were then washed three times with 30 mL of water, and
the phenolic compounds were recovered by elution with 20 mL of methanol. The resulting extracts
were concentrated in a rotary evaporator, frozen at −20 ◦C, freeze-dried, and kept under vacuum in a
desiccator in the dark.
2.3. Evaluation of Radical Scavenging and Inhibition of 5-Lipoxygenase Activities
2.3.1. Reducing Power, DPPH• Scavenging Activity
The ability of M. aquatica (0.025–0.25 mg/mL), L. dentata (0.05–0.25 mg/mL) and L. cardiaca
(0.05–0.25 mg/mL) ethanolic extracts in reducing iron (III) was assessed by the method described by
Catarino et al. [29]. In more detail, the different concentrations of each extract were mixed with 2.5 mL
of 0.2 M phosphate buffer (pH 6.6) and 2.5 mL of 1% potassium hexacyanoferrate [K3Fe(CN)6] aqueous
solutions. After 20 min of incubation at 50 ◦C, 2.5 mL of 4% trichloroacetic acid was added followed by
vigorous stirring. After that, 2.5 mL of each solution was transferred to new vials where 2.5 mL of
deionized water and 0.5 mL of 0.1% of iron chloride (FeCl3) were added, and the absorbance was then
measured at 700 nm. A linear regression analysis was carried out by plotting the mean absorbance
against the concentrations, and the EC50 value was determined considering the extract concentration
that provides 0.5 of absorbance. BHA was used as a reference compound.
The capacity of M. aquatica (0.025–0.25 mg/mL), L. dentata (0.05–0.5 mg/mL) and L. cardiaca
(0.05–0.5 mg/mL) to scavenge DPPH radical was performed according to the procedure previously
described [30]. Briefly, 0.1 mL of different concentrations of the extracts was prepared and added to
1.9 mL of a methanolic solution of DPPH•, followed by vigorous stirring. After 30 min of incubation in
the dark, the absorbance of the mixtures was measured in a spectrophotometer at 517 nm, against a
blank (absence of DPPH•). The radical scavenging activity of each ethanolic extract was calculated
as the percentage of DPPH• discoloration: % DPPH• scavenging = (Ac(0) − Ae(t))/Ac(0) × 100, where:
Ac(0) = Absorbance of the control at t = 0 min; Ae(t) = Absorbance of the extract at t = 30 min. Based
on the graphic values of the percentage of DPPH radical inhibition vs. extract concentration, the EC50
(concentration of the extract able to inhibit the 50% of the DPPH) of each extract was calculated.
Ascorbic acid was used as a reference.
2.3.2. NO• Scavenging Test
The ability of extracts in scavenging NO• followed the methodology previously reported by
Afonso et al. [31]. In brief, 100 µL of sodium nitroprusside (3.33 mM) in PBS 100 mM (pH = 7.4) were
added with 100 µL of the different sample concentrations (0.02–1 mg/mL) of each extract and incubated
for 10 min at room temperature under light irradiation. Sodium nitroprusside is known to decompose
in aqueous solution at physiological pH (7.2), producing NO•, and this, in turn, interacts with molecular
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oxygen, producing NO2−, which in the presence of Griess reagent (100 µL, 1% of sulfanilamide and
0.1% of naphthylethylenediamine dihydrochloride in 2.5% of phosphoric acid) produces a purple azo
dye. The measurement of the absorbance was determined spectrophotometrically at 562 nm. The EC50
value for the NO• scavenging activity was determined by plotting the percentage of inhibition of nitrite
generation in the presence of the plant extracts against the tested concentrations. Ascorbic acid was
used as the reference compound.
2.3.3. Inhibition of 5-Lipoxygenase (5-LOX)
The 5-LOX inhibitory assay was performed in a quartz 96-well plate according to the procedure
of Afonso et al. [31], with some modifications. For that, 20 µL of the extract sample solutions
(0.1–1.0 mg/mL for M. aquatica, 0.2–3.0 mg/mL for L. dentata and 0.2–3.0 mg/mL for L. cardiaca) and
20 µL of the 5-LOX work solution were added to each well and incubated at 37 ◦C in the plate reader
for 10 min. The reaction was then initiated by the addition of 40 µL of pre-heated linoleic acid (500 µM)
and the formation of (9Z, 11E)-(13S)-13-hydroperoxyoctadeca-9,11-dienoate was followed for 20 min
taking measurements every minute at 234 nm. The reaction rate at each inhibitor concentration was
calculated by determining the slope of the experimental values and the percentage of inhibition by the
following formula.
%inhibition =
v0 − v[inhibitor]
v0
× 100
where v0 corresponds to the reaction rate of control and v[inhibitor] to the reaction rate of the extract.
EC50 corresponds to the concentration of the tested extract able to inhibit the hydrolysis of the substrate
(linoleic acid) by about 50% (EC50). Ascorbic acid was used as the reference.
2.4. Evaluation of Biological Activity in Cellular Assays
2.4.1. Cell Culture and Treatments
The general cell culture procedures and those of MTT and ROS experiments followed the
procedures previously described by Pereira et al. [30]. The hydroethanolic extracts of M. aquatica, L.
dentata or L. cardiaca (final concentrations of 1–200 µg/mL) and/or potassium dichromate (K2Cr2O7)
(final concentrations of 1.5, 5, 25 or 500 µM) were dissolved in the culture medium. Twenty-four hours
after seeding, the cells’ culture medium was replaced by fresh culture medium containing the treatment
agents and the cells were maintained in culture, for 6 h or 72 h (in the MTT assay, to measure acute and
long-term toxicity, respectively) or 48 h (intracellular ROS).
2.4.2. MTT Assay
The viability of HepG2 cells was estimated by the formazan formation from the tetrazolium salt
by living cells, as previously described [30,32]. Cell viability was calculated as the percentage of living
cells compared to untreated (control) cells. Cisplatin (0.3 to 30 µg/mL) was used as a positive control.
2.4.3. Intracellular ROS Production
ROS production was analyzed by flow cytometry following the procedure described by
Pereira et al. [30]. After 48 h incubation of HepG2 cells with the hydroethanolic extracts and/or
potassium dichromate, the medium was replaced by RPMI culture medium containing 5 µg/mL of
the probe 2,7-dichlorofluorescein diacetate (DCFH-DA) for 30 min, and then cells were trypsinized
and resuspended in FBS free-medium. ROS generation was measured and analyzed in a cytometer
FACSort flow cytometer (BD Biosciences, San Jose, CA, USA) with CellQuest software (BD Biosciences).
The values were normalized to the percentage of ROS formation by the untreated cells.
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2.5. Analysis of the Phenolic Compounds
The analysis of phenolic compounds was performed by liquid chromatography under the general
conditions previously described by Catarino et al. [29]. Gradient elution was carried out with a mixture
of 0.1% (v/v) of formic acid in water (solvent A) and acetonitrile (solvent B), starting from 10 to 20% of
solvent B over 6 min, from 20 to 25% of solvent B over 12 min, from 25 to 34% over 30 min, increasing
to 100% at 37 min maintaining for 3 min, followed by the return to the initial conditions at 40 min.
The identification of phenolic compounds was corroborated by MS analysis using a Thermo LTQ XL
(Thermo Scientific, USA) ion trap MS apparatus equipped with an ESI source, operating in negative
mode, under the same conditions as previously described [28]. Additionally, the quantification of the
majority of the compounds in three plant extracts was performed by peak integration using the external
standard method, with the exact or structurally-related standard compounds. Considering the nature of
the phenolic compounds, eriodictyol-7-O-glucoside was used to quantify eriodictyol-O-rutinoside and
hesperetin-7-O-rutinoside; naringenin-7-O-glucoside was used to quantify naringenin-7-O-rutinoside;
luteolin-7-O-glucoside was used to quantify luteolin glycosides (peaks 6, 10 and 12); Flavonols (peaks
3, 9 and 11) were quantified with quercetin-7-O-rutinoside; Caffeic acid derivatives (peaks 1 and 16)
were quantified with rosmarinic acid; while verbascoside was used to quantified the phenylethanoid
glycosides (peaks 5, 7, 14 and 15). The linearity of the calibration curves, the regression coefficient (R2)
and the detection and quantification limits (LOD and LOQ, respectively) are represented in Table S1.
2.6. Statistical Analysis
All statistical analyses were performed with GraphPad Prism 6 statistical software (GraphPad, San
Diego, CA, USA). Data were expressed as mean ± S.D. or as mean ± S.E.M. of three to four independent
experiments performed at least in triplicate. The comparison between groups was performed by
one-way ANOVA, followed by Tukey’s test. Unpaired Student’s t-test was used for comparison
between two groups. Correlation analyses were performed using a two-tailed Pearson’s correlation
test. A difference was considered statistically significant when p < 0.05. For cellular assays, * p < 0.05;
*** p < 0.001 when compared to cells exposed to potassium dichromate in the absence of extracts;
### p < 0.01; #### p < 0.0001 when compared to untreated cells.
3. Results and Discussion
3.1. Antioxidant and Anti-Inflammatory Properties (in Chemical Models)
The hydroethanolic extracts of M. aquatica, L. dentata and L. cardiaca exhibited promising antioxidant
potential, as evaluated by DPPH• and reducing power assays, with potencies order of M. aquatica >
L. dentata > L. cardiaca and EC50 values ranging from 8.1 ± 1.3 to 18.3 ± 1.5 (corresponding to about
three to seven times higher than that of ascorbic acid) and from 51.9 ± 12.6 to 94.7 ± 12.1 (about
two to three times higher than that of BHA, used as the standard) (Table 1), respectively. In general,
the herein registered EC50 values for DPPH• are promising when compared to previous literature
data for methanol, hydromethanolic or aqueous (at 50 ◦C) extracts of M. aquatica (27–50.0 µg/mL
corresponding to 4–15 times that of ascorbic acid) [20,32], of L. dentata (48.7–71.1 µg/mL equivalent to
24-fold that of ascorbic acid) [17,18] and L. cardiaca (12–144 µg/mL) [33,34].
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Table 1. Yield of extraction (%), antioxidant and anti-inflammatory activities (EC50, µg/mL) of
M. aquatica, L. dentata and L. cardiaca extracts.
Sample Yield(%)
DPPH Scavenging
(µg/mL)
Reducing Power
(µg/mL)
NO• Scavenging
(µg/mL)
5-LOX Inhibition
(µg/mL)
M. aquatica 11.3 8.1 ± 1.3 a 51.9 ± 12.6 a 217.0 ± 19.0 a 174.5 ± 30.5 a
L. dentata 3.2 11.6 ± 1.1 b 78.9 ± 2.6 b 879.3 ± 192.8 b 237.9 ± 15.2 b
L. cardiaca 3.7 18.3 ± 1.5 c 94.7 ± 12.1 b >1000 >1000
AA - 2.5 ± 0.4 d - 92.0 ± 7.3 c 7.8 ± 1.0 c
BHA - - 27.1 ± 1.2 c - -
Mean values ± SD. Statistical analysis was performed by one-way ANOVA, followed by a Tukey’s test. In each
column, different letters (a–d) mean significant differences (p < 0.05); RP: Reducing Power; AA: Ascorbic acid; BHA:
Butylated hydroxyanisole; 5-LOX: 5-lipoxygenase.
The ability of M. aquatica, L. dentata and L. cardiaca hydroethanolic extracts to counteract
inflammatory events was evaluated by NO• scavenging and 5-LOX inhibitory methods. NO• is
a chemical mediator generated in biological tissues, while 5-LOX acts as a key enzyme in leukotrienes
biosynthesis. These molecules are potent mediators involved in various physiological processes and
are related to inflammatory conditions. As shown in Table 1, relevant activity was only observed for
the M. aquatica extract, particularly regarding its ability to scavenge NO•, which corresponded to about
a quarter of that of ascorbic acid (EC50 of 217.0 ± 19.0 and 92.0 ± 7.3 µg/mL, respectively). Please note
that the in-vivo anti-inflammatory effect has been previously described for M. aquatica [7] and L. dentata
hydroalcoholic extracts [18], although authors did not elucidate the molecular mechanisms behind
their effects. Hence, our results seem to suggest that, while NO• scavenging and LOX inhibition might
be partially involved in the inflammatory protection of M. aquatica extract, they do not play a role in
the case of L. dentata and L. cardiaca extracts.
3.2. Hepatoprotective Activities in HepG2 Cells
The human hepatocarcinoma cell line HepG2, which retains many specialized functions of normal
human hepatocytes, was used because this is a common model to screen possible protective effects of
compounds/extracts in liver cells. The MTT assay performed after 72 h exposure of these cells to M.
aquatica, L. dentata and L. cardiaca hydroethanolic extracts (1–200 µg/mL) allowed to conclude that the
latter was the one that least affected their metabolic activity (Figure 1). In fact, while this extract only
caused a negative impact on the viability of HepG2 cells at concentrations >100 µg/mL, the toxic limit
for M. aquatica and L. dentata was lower (50 µg/mL).
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Figure 1. Viability of HepG2 cells exposed for 72 h to a concentration range of cisplatin (0.3 to 30 µg/mL),
used here as a toxic positive control, or of hydroethanolic extracts (1 to 200 µg/mL) obtained from M.
aquatica, L. dentata and L. cardiaca. Values are means ± SD of the percentage of cell viability with respect
to control untreated cells.
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Considering the above results, the comparison of the potency of the three plant extracts in
protecting HepG2 from ROS generation and cell death was further investigated at 50 µg/mL [29].
In this and previous studies, we have used potassium dichromate (K2Cr2O7) as a model aggressive
agent because of its ability to generate oxidative stress and interact with intracellular macromolecules
causing DNA damage [35]. K2Cr2O7 affects HepG2 cells through multiple mechanisms, which overall
cause a massive increase of ROS and ultimately lead to cell death through apoptosis and necrosis.
These effects are dependent on the time and levels of exposure to the toxic substance [5,30,36,37].
As shown in Figure 2, the treatment of HepG2 with K2Cr2O7 at 5 µM and 25 µM deregulated
ROS production versus cellular antioxidant balance, resulting in increased ROS intracellular levels
by over 1.7-fold and 2.4-fold, respectively. These effects could be counteracted by the presence of
the plant extracts, particularly from M. aquatica and L. dentata origin. Of note, regardless, being less
active than M. aquatica extract in DPPH• and reducing power assays, L. dentata extract showed the
highest effectiveness in attenuating ROS formation in HepG2 cells. Thus, a significant decrease in the
rate of K2Cr2O7 induced ROS production (23% and 31%, at 5 µM and 25 µM, respectively), as well as
under non-stimulated conditions of ROS production (36%) was observed. In contrast, the protective
effects of M. aquatica were only significant for the most-toxic conditions, i.e., during incubation with
25 µM K2Cr2O7.
Antioxidants 2019, 8, x FOR PEER REVIEW 7 of 13 
than M. aquatica extract in DPPH• and reducing power assays, L. dentata extract showed the highest 
effectiveness in attenuating ROS formation in HepG2 cells. Thus, a significant decrease in the rate of 
K2Cr2O7 induced ROS production (23% and 31%, at 5 μM and 25 μM, respectively), as well as under 
non-stimulated conditions of ROS production (36%) was observed. In contrast, the protective effects 
of M. aquatica were only significant for the most-toxic conditions, i.e., during incubation with 25 μM 
K2Cr2O7. 
*
* ***
 
Figure 2. Effect of M. aquatica, L. dentata and L. cardiaca hydroethanolic extracts (at 50 μg/mL) in ROS 
production in HepG2 cells in the absence or presence of 5 or 25 μM of potassium dichromate. Values 
are expressed as means ± S.D. of percentage of ROS production with respect to the control (untreated 
cells). K2Cr2O7, potassium dichromate; Ma, M. aquatica extract; Ld, L. dentata extract; Lc, L. cardiaca 
extract. 
The possible protection activity of extracts towards loss of cell viability induced by K2Cr2O7 was 
also tested in two cytotoxic models, namely 500 μM K2Cr2O7 for 6 h (acute toxicity) and 1.5 μM 
K2Cr2O7 for 72 h (long-term toxicity) [38]. Overall, the exposure to the toxic agent caused a decrease 
in cell viability of about 45% and 30%, respectively (Figure 3). These results showed that none of the 
extracts could prevent the loss of viability in cells cultured under a strong toxic treatment but still, 
both M. aquatica extract (50 μg/mL) and M. aquatica/L. dentata mixture (25 μg/mL each) were able to 
protect the cells from a mild toxic insult. Our results suggest that M. aquatica does effectively reduce 
the levels of ROS in liver cells. No clear inhibition of ROS production was observed when this was 
induced by low concentrations of K2Cr2O7, nevertheless, at higher concentrations and hence higher 
levels of oxidative stress, a significant antioxidant effect of M. aquatica extract was seen (Figure 2). 
Since M. aquatica and L. dentata were able to reduce ROS production induced by K2Cr2O7, but only M. 
aquatica partially prevented cell death induced by a mild dose of the toxic compound over the long 
term, this suggests that the cytoprotective effect of M. aquatica could be mediated through ROS-
dependent scavenging action; however, this must be confirmed by other assays which evidence the 
mechanisms. In contrast, the antioxidant protection conferred by L. dentata was not translated to an 
evident defense against the K2Cr2O7-induced long-term toxicity effect. 
Figure 2. Effect of M. aquatica, L. dentata and L. cardiaca hydroethanolic extracts (at 50 µg/mL) in ROS
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K2Cr2O7, potassium dichromate; Ma, M. aquatica extract; Ld, L. dentata extract; Lc, L. cardiaca extract.
The possible protection activity of extracts towards loss of cell viability induced by K2Cr2O7
was also tested in two cytotoxic models, namely 500 µM K2Cr2O7 for 6 h (acute toxicity) and 1.5 µM
K2Cr2O7 for 72 h (long-term toxicity) [38]. Overall, the exposure to the toxic agent caused a decrease in
cell viability of about 45% and 30%, respectively (Figure 3). These results showed that none of the
extracts could prevent the loss of viability in cells cultured under a strong toxic treatment but still,
both M. aquatica extract (50 µg/mL) and M. aquatica/L. dentata mixture (25 µg/mL each) were able to
protect the cells from a mild toxic insult. Our results suggest that M. aquatica does effectively reduce
the levels of ROS in liver cells. No clear inhibition of ROS production was observed when this was
induced by low concentrations of K2Cr2O7, nevertheless, at higher concentrations and hence higher
levels of oxidative stress, a significant antioxidant effect of M. aquatica extract was seen (Figure 2). Since
M. aquatica and L. dentata were able to reduce ROS production induced by K2Cr2O7, but only M. aquatica
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partially prevented cell death induced by a mild dose of the toxic compound over the long term,
this suggests that the cytoprotective effect of M. aquatica could be mediated through ROS-dependent
scavenging action; however, this must be confirmed by other assays which evidence the mechanisms.
In contrast, the antioxidant protection conferred by L. dentata was not translated to an evident defense
against the K2Cr2O7-induced long-term toxicity effect.
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3.3. Phenolic Characterization of . aq ta and L. cardiaca Hydroethanolic Extracts
Considering that the bioacti f . aquatica, L. dent t and L. cardiaca are mainly
claimed to be associated with their p li tit ents [7,18,34], the phenoli composition of the
three extracts was herein evaluated. erall, t e total a ounts of phenolic compounds in the extracts
followed the sequence order of L. cardiaca > . aquatica > L. dentata, with values of 500 ± 49, 307 ± 29
and 94 ± 4 µg/mg, respectively (data not shown). Moreover, their phenolic profiles were quite different
to each other (Figure S1 and Table 2).
Thus, while the extract from M. aquatica origin was mainly composed of flavanones, such as
eriodictyol, naringenin and hesperitin glycosides, L. dentata extract was rich in rosmarinic acid, reaching
up to 72% of the total quantified phenolic compounds. In turn, phenylethanoid glycosides comprised
the most prevalent phenolics in L. cardiaca extracts, specially lavandulifolioside and verbascoside
(254 ± 36 and 137 ± 20 µg/mg extract, respectively). In general, the chemical composition of the
extract analyzed in the present study agreed with previous reported data regarding these three
plants [18,23,39,40]. Nevertheless, this is the first time that leucoseptoside A (MW 638, 31.5 ± 4.6 µg/mg
extract) and leonoside B (MW 784, 25.1 ± 4.7 µg/mg extract) have been detected in L. cardiaca extracts.
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Table 2. Phenolic compounds of M. aquatica, L. dentata and L. cardiaca hydroethanolic extracts determined
by UHPLC-DAD-ESI-MSn.
- Plant Extract
M. aquatica L. dentata L. cardiaca
Peak RT(min) λmax (nm) Compound
ESI—MSn
Fragmentation
(m/z)
Phenolic Content (µg/mg of extract)
Caffeic acid derivatives
1 8.2 290,329 Caffeic acid glc 341→179→135 - - 3.7 ± 0.8
16 21.1 290,328 Rosmarinic acid 359→179→135, 161 64.2 ± 8.8 67.8 ± 6.7 -
Phenylethanoid glycosides
5 16.7 290,329 Lavandulifolioside 755→593→461→315 - - 253.6 ± 35.8
7 17.5 290,329 Verbascoside 623→461→315→135 - - 137.4 ± 19.9
14 19.4 ND Leucoseptoside A 637→461→315→135 - - 31.5 ± 4.6
15 20.0 ND Leonoside B 783→607→475→329 - - 25.1±4.7
Flavones
6 16.8 254,267,345 Luteolin-7-O-rut 593→285→241 43.3 ± 10.0 - -
10 18.1 253,267,345 Luteolin-7-O-glcA 461→285→241 D 26.2 ± 4.0 -
12 18.9 ND Luteolin-7-O-rut 593→285→257 - - D
17 21.1 266,329 Apigenin-7-O-gl 431→269→225 - D -
18 26.3 266,330 Apigenin-7-O-(6”acetyl)glc 473→269, 413 - D -
Flavonols
2 8.2 ND Rutin-O-glc 771→609→301 - D -
3 13.7 ND Quercetin-3-O-soph 625→301→179 - - 5.7 ± 1.1
9 18.0 256,267,355 Rutin 609→301→179 - - 15.8 ± 2.1
11 18.9 256,267,357 Quercetin-3-O-glc 463→301→179 - - 24.9 ± 3.8
Flavanones
4 15.0 283,325sh Eriodictyol-O-rut 595→287→151→107 144.6 ± 22.4 - -
8 17.9 282,333sh Naringenin-7-O-rut 579→271→151 24.4 ± 3.7 - -
13 19.5 283,325sh Hesperetin-7-O-rut 609→301→286→241 25.9 ± 3.6 - -
D, Detected; Glc, Glucoside; GlcA, Glucuronide; RT, retention time; Rut, Rutinoside; Soph, Sophoroside; Mean values
± standard deviations; Numbers correspond to the UHPLC-DAD-ESI-MSn peaks described in chromatograms in
Figure 1. Supplementary Material S1.
Moreover, it must be highlighted that regardless of being the richest in total phenolic compounds,
the L. cardiaca extract showed weak biological activity, both in the chemical and cellular models used
here, thus indicating that their main phenolic compounds have low antioxidant and cytoprotective
properties. In turn, the main phenolic components of M. aquatica or L. dentata extracts can in part
be associated with the observed hepatoprotection due to antioxidant and additional mechanisms.
Table 3 summarizes the Pearson correlation coefficients between the amounts of classes of phenolic
components or major individual phenolic compounds found in the three hydroethanolic extracts and
the results obtained in radical scavenging, 5-LOX inhibition assays and biological experiments.
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Table 3. Correlation coefficients between the amounts of phenolic components of M. aquatica, L. dentata
and L. cardiaca hydroethanolic extracts and the data from the radical scavenging, 5-LOX inhibition
assays and biological experiments.
Assay Flavan Flav Flavo PEG RAc
DPPH 0.889 0.986 −0.841 −0.841 0.815
RP 0.973 0.917 −0.688 −0.688 0.653
NO 0.990 0.878 −0.620 −0.620 0.582
ROS 0.373 0.856 −0.990 −0.990 0.996
CytP 0.803 0.284 0.115 0.115 −0.161
Values expressed as Pearson Correlation Coefficient R; CytP—Cytoprotection (MTT 72h); PEG—Phenylethanoid
glycosides; DPPH—DPPH radical scavenging activity; Flav—Flavones; Flavan—Flavanones; Flavo—Flavonols;
NO—Nitric oxide radical scavenging capacity; RP—reducing power potential; RAc—Rosmarinic Acid;
ROS—Protection form ROS production (25 µM K2Cr2O7).
The most abundant hydroxycinnamic acid present in L. dentata and M. aquatica extracts, i.e.,
rosmarinic acid, was well correlated with the antioxidant effect measured by DPPH• (0.815) and
ROS-scavenging protection in HepG2 cells (0.996). Indeed, rosmarinic acid has demonstrated to
possess high scavenging ability via direct and indirect ROS-scavenging activities, including in the cell
model herein used [30,41,42]. Additionally, rosmarinic acid is a strong scavenger of ONOO− and other
free radicals [3,43].
Concerning flavonoid compounds, the antioxidant effects measured by reducing power and for
counteracting DPPH• and NO• showed to be in good agreement with the content of flavones and
flavanones, with Pearson correlation coefficients of about 0.9. Of note, L. dentata and M. aquatica extracts
contained moderate amounts of luteolin derivatives, and overall, the content of these flavones has
a good correlation with almost all biological assays carried out in the present study. These data are
consistent with the available literature, in which luteolin has been described as a cytoprotective agent
in HepG2 and PC12 cells, in part due to its ROS scavenging activity [30,44].
The cytoprotective effect found in our assays was reasonably well correlated with the amounts
of flavanones (0.803), which could explain the high activity of M. aquatica hydroethanolic extract,
mainly composed of eriodictyol-7-O-rutinoside. In fact, it has been described that this compound has
a lipoxygenase inhibitor action [45], and eriodictyol has been reported to reduce NO• production in
macrophages [27,46]. Previous studies have also shown the efficacy of eriodictyol in ROS scavenging
activity in HepG2 [30] and retinal cells [47]. In addition, a cytoprotective effect under similar conditions
to these used in the present work has been reported [30]. Finally, M. aquatica hydroethanolic extract
could exert effective protection through interference with proapoptotic events that lead to cell death,
because eriodictyol is a potent inhibitor of key apoptotic steps, such as pro-caspase-3 and pro-caspase-9
cleavage and the release of cytochrome C [46,48].
4. Conclusions
The present study suggests the potential beneficial effect on liver cells of hydroethanolic extracts
obtained from M. aquatica and L. dentata cultivated under an organic cultivation system. While
M. aquatica extract exerts a cytoprotective effect on HepG2 cells, L. dentata extract has ROS-scavenging
efficiency. Focusing on the phenolic profiles of the most-active extracts, their content in flavanones and
in rosmarinic acid is possibly associated with the antioxidant and hepatoprotective effects of M. aquatica
and L. dentata, respectively, and the extracts are proposed as valuable sources of natural metabolites
with potential health-benefit properties.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3921/8/8/267/s1,
Figure S1: Chromatographic representation of Mentha aquatica (a), Lavandula dentata (b) (both at 280 nm) and
Leonurus cardiaca (c) (at 340 nm) hydroethanolic extracts, Table S1: Linearity, LOD and LOQ of standard compounds
used as references.
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